Teva's generic Saxenda is the first generic GLP-1 indicated for weight loss. Richardsen added, “This is the fifth first-to-market entry of a Teva generic this year and is an important addition to Teva ...
Aug 28 (Reuters) - The U.S. Food and Drug Administration has approved Teva Pharmaceuticals' (TEVA.TA), opens new tab cheaper generic version of Novo Nordisk's (NOVOb.CO), opens new tab older ...
Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback